The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
In the five weeks since Donald Trump returned as U.S. president, the FDA, NIH and CDC have been thrown into disarray, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback